Cholangiocarcinoma
- Cholangiocarcinoma (CCA) is cancer of the bile-duct lining — the plumbing that drains the liver, not the liver meat itself.
- Location is everything: intrahepatic (a mass deep in the liver), perihilar (where the ducts merge at the liver hilum — the classic "Klatskin" spot), and distal (down near the pancreas).
- The signature trick on imaging is delayed, progressive enhancement — the tumor lights up slowly and stays bright, because it's full of fibrous scar tissue.
- A duct that suddenly narrows with dilated ducts ballooning upstream of it is the finding that should make you nervous.
- It loves to track along ducts and nerves, so it's sneakier and harder to fully resect than it first looks.
Your liver makes bile and pipes it out through a branching tree of ducts, the way rain gutters collect water and funnel it to a single downspout. Cholangiocarcinoma is cancer that grows from the lining of that plumbing. And like a clog in a real downspout, the first sign something's wrong is usually upstream: everything backs up and swells.
Where it lives (and why you should care)
CCA is one of those tumors radiologists describe by its address, because the address changes everything — how it looks, how it's treated, and how bad the news is.
| Type | Where | What it looks like |
|---|---|---|
| Intrahepatic | Deep in the liver | A solid mass with capsular retraction. |
| Perihilar ("Klatskin") | At the hilum, where right and left ducts join | Often a subtle stricture, not a bulky mass. |
| Distal | Lower duct, near the pancreas head | Stricture that mimics pancreatic cancer. |
Perihilar is the most common flavor and also the most aggravating, because it frequently grows along the duct wall rather than forming an obvious lump. You don't see a tumor so much as you see what it did — a pinched duct with dilated branches fanning out above it.
"Klatskin tumor" is just the nickname for a perihilar cholangiocarcinoma sitting at the confluence of the right and left hepatic ducts. Same disease, fancier zip code.
The enhancement fingerprint
Here's the single most useful concept, so I'll belabor it. CCA is stuffed with dense fibrous tissue — think beef jerky more than a juicy grape. Contrast seeps into that scar slowly and then gets stuck there, so the tumor enhances late and lingers.
On a multiphase CT or MRI, you'll often see a rim of enhancement early, then progressive filling-in on the delayed images while the rest of the liver has already washed out. That "bright late, stays bright" pattern is the opposite of what hepatocellular carcinoma does — HCC famously lights up fast and washes out fast. Two liver cancers, two completely different personalities. Memorize the contrast and you've done half the work.
Delayed, progressive, persistent enhancement = think cholangiocarcinoma (and other desmoplastic, fibrous tumors). Fast in, fast out = think HCC.
Reading the duct tree
Because so much of CCA is about obstruction, the bile ducts are your road map. The non-invasive way to photograph that tree is MRCP — an MRI sequence that makes fluid (bile) glow brilliantly white, drawing the whole biliary tree like a glowing river system.
What you're hunting for: an abrupt cutoff or a tight, irregular stricture, with ducts dilated upstream and normal-caliber downstream. The "transition point" is where the trouble is.
A benign stricture from primary sclerosing cholangitis or prior surgery can look maddeningly similar to CCA — both narrow the duct. PSC even predisposes to cholangiocarcinoma, so a dominant or rapidly changing stricture in a PSC patient is a red flag, not a reassurance. When the ducts look weird, compare with priors and keep cancer on the list.
Why it's sneakier than it looks
CCA has two bad habits worth knowing. First, it tends to creep along the duct wall and along nearby nerves, so the visible tumor is often just the tip — the disease extends farther than the obvious mass. That's a big reason surgeons struggle to get clean margins.
Second, it doesn't always make a tumor you can point at. Sometimes the only sign is that disappointing stricture and a sea of dilated ducts behind it. So part of the radiologist's job is to map how far the tumor reaches up each duct branch, because that determines whether a surgeon can even attempt a cure.
When you report a perihilar CCA, the surgeon mostly wants to know one thing: how far up the right and left ducts does it go? That longitudinal extent — not the diameter — usually decides resectability.
Don't confuse it with its neighbors
A distal CCA squeezing the lower duct looks a lot like pancreatic head cancer, and an intrahepatic mass can mimic liver metastases — especially metastatic adenocarcinoma, which can also enhance late and pull the liver capsule inward. The enhancement pattern, the duct mapping, and the clinical context sort them out, but honesty requires admitting these can be genuinely hard calls.
When the pipes need help
Whatever the cause, a blocked biliary tree backs up bile, turns patients yellow, and gets infected. If the tumor can't be removed, the ducts often still need to be drained — which is where biliary drainage and stenting comes in, threading a tube past the blockage to get bile flowing again.
If you remember one thing: cholangiocarcinoma is the bile duct's own cancer, it announces itself with a stricture and upstream dilation, and its calling card is that slow, stubborn, stays-bright enhancement from all that internal scar tissue.